Management for Decreased appetite and Hard stools for a female patient?
Management for decreased appetite
decreased appetite management treatment
anorexia causes evaluation nutritional support
| Category | Examples |
|---|---|
| GI | Gastritis, GERD, gastroparesis, constipation, liver disease, IBD |
| Metabolic/Endocrine | Hypothyroidism, diabetes, adrenal insufficiency, hypercalcemia |
| Infections | TB, H. pylori, hepatitis |
| Psychiatric | Depression, anxiety, eating disorders |
| Medications | Antibiotics, opioids, metformin, iron, SSRIs, chemotherapy |
| Chronic disease | CKD, heart failure, malignancy, liver cirrhosis |
| Nutritional deficiency | Zinc deficiency, B12, folate |
| Physiological | Aging, pregnancy (first trimester) |
| Drug | Dose | Notes |
|---|---|---|
| Megestrol acetate | 160–800 mg/day | Effective in cancer/HIV cachexia; risk of DVT, adrenal suppression |
| Mirtazapine | 7.5–15 mg at night | Useful if depression coexists; causes weight gain |
| Cyproheptadine | 4 mg TID | Mild antihistamine; used in functional anorexia |
| Dronabinol (cannabinoid) | 2.5 mg BID | Used in cancer/HIV anorexia |
| Corticosteroids | Short course | Short-term appetite boost in palliative/advanced disease |
| Zinc supplementation | 25–50 mg/day | If zinc deficiency is confirmed or suspected |
| Metoclopramide | 10 mg before meals | If gastroparesis is contributing |
Key principle: Treat the cause first. Appetite stimulants are adjunctive — they do not replace addressing the root problem. If appetite loss is unexplained, persistent, or accompanied by weight loss, full workup is warranted.